|
시장보고서
상품코드
1983133
소 백신 시장 : 백신 유형별, 질환 적응증별, 소 유형별, 투여 경로별, 최종사용자별, 유통 채널별, 지역별Cattle Vaccine Market, By Vaccine Type, By Disease Indication, By Cattle Type, By Route of Administration, By End User, By Distribution Channel, By Geography |
||||||
소 백신 시장은 2026년에 41억 3,000만 달러로 추정되며, 2033년까지 61억 7,000만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 5.9%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 41억 3,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 5.90% | 2033년 시장 규모 예측: | 61억 7,000만 달러 |
전 세계 소 백신 시장은 수의학 산업에서 중요한 부문으로, 전 세계 가축의 감염병을 예방하기 위해 설계된 다양한 면역 생물학적 제품을 포괄하는 시장입니다.
축산업이 동물의 건강과 복지를 중시하는 방향으로 진화하고 있는 가운데, 소 백신은 가축의 면역력을 유지하고 지속가능한 농업 생산성을 보장하기 위한 필수적인 수단으로 자리매김하고 있습니다. 이 백신은 소 호흡기질환 복합체, 구제역, 브루셀라병, 탄저병, 클로스트리듐 감염증 등 다양한 세균성, 바이러스성, 기생충성 질병으로부터 소를 보호합니다.
시장에는 약독성 생백신, 불활성화 백신, 서브유닛 백신, 재조합 백신 등 다양한 백신 유형이 있으며, 각 유형은 특정 치료 목적과 투여 프로토콜에 따라 다릅니다. 세계 인구 증가에 따라 단백질이 풍부한 식품에 대한 수요가 증가함에 따라 소 사육 사업은 크게 확대되고 있으며, 이에 따라 견고한 질병 예방 전략이 필수적입니다.
이 시장은 새로운 보조제, 개선된 전달 시스템, 보다 광범위한 예방 효과를 제공하는 혼합 백신 등 백신 개발의 지속적인 기술 발전이 특징입니다. 각 지역의 규제 프레임워크가 백신의 안전성과 유효성을 보장하는 한편, 수의학 전문가와 축산농가들은 사후 치료적 접근보다 예방적 건강관리 조치의 경제적 이점을 점점 더 많이 인식하고 있으며, 이에 따라 소 백신은 현대 축산 관행에서 필수적인 요소로 자리매김하고 있습니다.
시장 역학
세계 소 백신 시장은 지속적인 성장 궤도를 뒷받침하는 몇 가지 강력한 촉진요인에 의해 주도되고 있습니다. 주요 촉진요인은 소고기와 유제품에 대한 전 세계 수요 증가로 인한 소 사육두수 증가와 종합적인 질병 예방 전략을 필요로 하는 집약적인 축산 방식에 기인합니다. 인수공통전염병과 소에서 사람으로의 감염 가능성에 대한 인식이 높아지면서, 특히 축산업이 중요한 경제활동인 개발도상국에서는 가축 예방접종 프로그램에 대한 관심이 높아지고 있습니다.
마커 백신, 내열성 제제, 무침 투여 시스템 도입 등 백신 개발의 기술적 진보는 백신의 효능과 편의성을 향상시켜 축산 농가의 백신 접종률을 높이고 있습니다.
동물 위생 프로그램에 대한 정부의 노력과 규제적 지원, 그리고 동물 건강 관리 의료비 증가와 함께 시장 확대는 더욱 가속화되고 있습니다. 그러나 시장에는 눈에 띄는 제약도 존재합니다. 예를 들어, 백신 개발 및 규제 당국의 승인 절차에 소요되는 높은 비용은 가격에 민감한 시장에서의 접근을 제한하는 요인이 될 수 있습니다. 또한, 콜드체인에 의한 보관 요건은 특히 인프라가 부족한 외딴 농업 지역에서는 물류 문제를 야기합니다.
또한, 일부 축산 농가의 백신 접종에 대한 거부감, 잠재적 부작용에 대한 우려, 대체 질병 관리 기법의 존재는 시장 침투를 방해할 수 있습니다. 그럼에도 불구하고, 신흥국에서의 축산 사업 확대, 정밀 축산 기술 도입 증가, 그리고 유기농 및 무항생제 육류 생산에 대한 관심 증가로 인해 큰 비즈니스 기회가 창출되고 있습니다. 재조합 DNA 기술과 나노기술 플랫폼을 활용한 차세대 백신 개발은 수익성 높은 전망을 보여주고 있으며, 백신 제조업체와 축산농가와의 전략적 제휴는 새로운 시장 채널을 창출하고 유통망을 강화하고 있습니다.
본 조사의 주요 특징
- 세계의 소 백신 시장에 대해 조사 분석했으며, 2025년을 기준 연도로 하여 예측 기간(2026-2033년)의 시장 규모(10억 달러)와 CAGR(연평균 성장률)을 예측한 보고서입니다.
- 이 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트도 제공합니다.
- 이 보고서는 다음과 같은 매개 변수를 기반으로 세계 소 백신 시장의 주요 기업 프로파일을 작성했습니다. 구체적으로 기업 개요, 제품 포트폴리오, 주요 하이라이트, 재무 실적 및 전략 등입니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 유형 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 금융 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 소 백신 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 쉽게 의사결정을 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 소 백신 시장 : 백신 유형별, 2021-2033년
제5장 세계의 소 백신 시장 : 질환 적응증별, 2021-2033년
제6장 세계의 소 백신 시장 : 소 유형별, 2021-2033년
제7장 세계의 소 백신 시장 : 투여 경로별, 2021-2033년
제8장 세계의 소 백신 시장 : 최종사용자별, 2021-2033년
제9장 세계의 소 백신 시장 : 유통 채널별, 2021-2033년
제10장 세계의 소 백신 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 애널리스트의 추천
제13장 참고문헌 및 조사 방법
KSM 26.04.15Cattle Vaccine Market is estimated to be valued at USD 4.13 Bn in 2026 and is expected to reach USD 6.17 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 4.13 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.90% | 2033 Value Projection: | USD 6.17 Bn |
The global cattle vaccine market represents a critical segment of the veterinary healthcare industry, encompassing a comprehensive range of immunobiological products designed to prevent infectious diseases in cattle populations worldwide.
As livestock farming continues to evolve with increasing emphasis on animal health and welfare, cattle vaccines have become indispensable tools for maintaining herd immunity and ensuring sustainable agricultural productivity. These vaccines protect cattle against various bacterial, viral, and parasitic diseases including bovine respiratory disease complex, foot-and-mouth disease, brucellosis, anthrax, and clostridial infections, among others.
The market encompasses multiple vaccine types including live attenuated, inactivated, subunit, and recombinant vaccines, each serving specific therapeutic purposes and administration protocols. With the global population surge driving increased demand for protein-rich food sources, cattle farming operations are scaling up significantly, necessitating robust disease prevention strategies.
The market is characterized by continuous technological advancements in vaccine development, including novel adjuvants, improved delivery systems, and combination vaccines that offer broader protection spectrums. Regulatory frameworks across different regions ensure vaccine safety and efficacy, while veterinary professionals and livestock producers increasingly recognize the economic benefits of preventive healthcare measures over reactive treatment approaches, positioning cattle vaccines as essential components of modern animal husbandry practices.
Market Dynamics
The global cattle vaccine market is propelled by several compelling drivers that underscore its sustained growth trajectory. The primary driver stems from the escalating global demand for beef and dairy products, necessitating larger cattle populations and intensive farming practices that require comprehensive disease prevention strategies. Rising awareness about zoonotic diseases and their potential transmission from cattle to humans has intensified focus on livestock immunization programs, particularly in developing regions where cattle farming constitutes a significant economic activity.
Technological advancements in vaccine development, including the introduction of marker vaccines, thermostable formulations, and needle-free delivery systems, have enhanced vaccine efficacy and convenience, driving adoption rates among livestock producers.
Government initiatives and regulatory support for animal health programs, coupled with increasing veterinary healthcare expenditure, further accelerate market expansion. However, the market faces notable restraints including the high cost of vaccine development and regulatory approval processes, which can limit accessibility in price-sensitive markets. Cold chain storage requirements pose logistical challenges, particularly in remote agricultural regions with inadequate infrastructure.
Additionally, vaccine hesitancy among some livestock producers, concerns about potential adverse reactions, and the availability of alternative disease management approaches can impede market penetration. Nevertheless, significant opportunities emerge from expanding cattle farming operations in emerging economies, increasing adoption of precision livestock farming technologies, and growing emphasis on organic and antibiotic-free meat production. The development of next-generation vaccines utilizing recombinant DNA technology and nanotechnology platforms presents lucrative prospects, while strategic partnerships between vaccine manufacturers and livestock producers create new market channels and enhance distribution networks.
Key Features of the Study
- This report provides in-depth analysis of the global cattle vaccine market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global cattle vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Zoetis, Boehringer Ingelheim Animal Health, Merck Animal Health MSD Animal Health, Elanco Animal Health, Ceva Sante Animale, HIPRA, Virbac, Vaxxinova, IDT Biologika, Biogenesis Bago, Indian Immunologicals Ltd, Hester Biosciences Limited, Jinyu Bio-Technology Co Ltd, China Animal Husbandry Industry Co Ltd CAHIC, and Bioveta a.s. International
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global cattle vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cattle vaccine market
Market Segmentation
- Vaccine Type Insights (Revenue, USD Bn, 2021 - 2033)
- Combination (Multivalent) Vaccines
- Inactivated (Killed) Vaccines
- Live Attenuated Vaccines
- Recombinant Vaccines
- Toxoid Vaccines
- DNA / Vector-Based Vaccines
- Disease Indication Insights (Revenue, USD Bn, 2021 - 2033)
- Bovine Respiratory Diseases (BRD Complex, IBR, BRSV, PI3)
- Foot and Mouth Disease (FMD)
- Clostridial Diseases (Blackleg, Enterotoxemia, Tetanus)
- Bovine Viral Diarrhea (BVD)
- Leptospirosis
- Mastitis
- Brucellosis
- Anthrax
- Others (Johne's disease, Bluetongue, etc.)
- Cattle Type Insights (Revenue, USD Bn, 2021 - 2033)
- Dairy Cattle
- Beef Cattle
- Breeding Stock
- Calves / Young Stock
- Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
- Injectable Vaccines
- Intranasal Vaccines
- Oral Vaccines
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Commercial Dairy Farms
- Beef Farms & Ranches
- Veterinary Clinics & Hospitals
- Government & Institutional Vaccination Programs
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Direct Sales (Manufacturers to Farms/Institutions)
- Veterinary Hospitals & Clinics
- Veterinary Pharmacies & Distributors
- Government Procurement Programs
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Zoetis
- Boehringer Ingelheim Animal Health
- Merck Animal Health MSD Animal Health
- Elanco Animal Health
- Ceva Sante Animale
- HIPRA
- Virbac
- Vaxxinova
- IDT Biologika
- Biogenesis Bago
- Indian Immunologicals Ltd
- Hester Biosciences Limited
- Jinyu Bio-Technology Co Ltd
- China Animal Husbandry Industry Co Ltd CAHIC
- Bioveta a.s. International
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Cattle Vaccine Market, By Vaccine Type
- Global Cattle Vaccine Market, By Disease Indication
- Global Cattle Vaccine Market, By Cattle Type
- Global Cattle Vaccine Market, By Route of Administration
- Global Cattle Vaccine Market, By End User
- Global Cattle Vaccine Market, By Distribution Channel
- Global Cattle Vaccine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Cattle Vaccine Market, By Vaccine Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Combination (Multivalent) Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Inactivated (Killed) Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- DNA / Vector-Based Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
5. Global Cattle Vaccine Market, By Disease Indication, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Bovine Respiratory Diseases (BRD Complex, IBR, BRSV, PI3)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Foot and Mouth Disease (FMD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Clostridial Diseases (Blackleg, Enterotoxemia, Tetanus)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Bovine Viral Diarrhea (BVD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Leptospirosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Mastitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Brucellosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Anthrax
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Others (Johne's disease, Bluetongue, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
6. Global Cattle Vaccine Market, By Cattle Type, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Dairy Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Beef Cattle
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Breeding Stock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Calves / Young Stock
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
7. Global Cattle Vaccine Market, By Route of Administration, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Injectable Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Intranasal Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Oral Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
8. Global Cattle Vaccine Market, By End User, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Commercial Dairy Farms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Beef Farms & Ranches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Veterinary Clinics & Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Government & Institutional Vaccination Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
9. Global Cattle Vaccine Market, By Distribution Channel, 2021-2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Direct Sales (Manufacturers to Farms/Institutions)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Veterinary Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Veterinary Pharmacies & Distributors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
- Government Procurement Programs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
10. Global Cattle Vaccine Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Cattle Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Zoetis
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Boehringer Ingelheim Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck Animal Health MSD Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Elanco Animal Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ceva Sante Animale
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- HIPRA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Virbac
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Vaxxinova
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- IDT Biologika
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biogenesis Bago
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Indian Immunologicals Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hester Biosciences Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Jinyu Bio-Technology Co Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- China Animal Husbandry Industry Co Ltd CAHIC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bioveta a.s. International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
